Drug Shortage Report for RAN-OLANZAPINE ODT
Report ID | 103678 |
Drug Identification Number | 02414104 |
Brand name | RAN-OLANZAPINE ODT |
Common or Proper name | OLANZAPINE ODT |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 10MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 28 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-01-16 |
Estimated end date | 2020-02-28 |
Actual end date | 2020-01-30 |
Shortage status | Resolved |
Updated date | 2020-02-02 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-02-02 | French | Compare |
v3 | 2020-02-02 | English | Compare |
v2 | 2020-01-20 | French | Compare |
v1 | 2020-01-20 | English | Compare |
Showing 1 to 4 of 4